Summary & Overview
HCPCS Level II J2780: Injection of Ranitidine Hydrochloride, 25 mg
HCPCS Level II code J2780 denotes a 25 mg injection of ranitidine hydrochloride, an H2-receptor antagonist used historically for acid suppression. Nationally, this code matters for accurate reporting of drug administration services and for tracking utilization of injectable gastroenterology-related medications in outpatient and hospital settings. Coverage and payment policies for injectable ranitidine can affect facility and professional billing workflows and inventory management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for ranitidine injections, typical sites of service where J2780 is billed, and the payer landscape relevant to reimbursement and claims processing. The publication also summarizes available benchmarks and policy considerations tied to HCPCS reporting, highlights billing alignment for injectable drug administrations, and notes areas where data is not available in the input.
This summary is designed for clinicians, billing professionals, and policy analysts seeking a national-level reference for HCPCS Level II code J2780 and its role in outpatient and hospital outpatient drug administration reporting.
Billing Code Overview
HCPCS Level II code J2780 represents an injection of ranitidine hydrochloride, 25 mg. This code is used to report a single administration of ranitidine hydrochloride at the specified dose.
Service Type: Drug administration (injectable medication)
Typical Site of Service: Outpatient infusion/clinic or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an urgent care clinic or hospital emergency department with acute gastrointestinal bleeding, severe gastritis, peptic ulcer disease with active bleeding, or as premedication before endoscopic procedures. The clinician documents intravenous administration of J2780 (injection, ranitidine hydrochloride, 25 mg) when a rapid H2-receptor antagonist effect is required to reduce gastric acid secretion and stabilize the patient prior to diagnostic or therapeutic intervention. The workflow includes assessment of allergy status and current medications, establishing IV access, ordering J2780 on the medication administration record, administering the dose per facility protocol, monitoring vital signs and response, and documenting the medication name, dose, route, time, lot number, and administering clinician. Ranitidine injection is often used when oral administration is not possible or when a parenteral H2 blocker is preferred for acute management. The medication may be given alone or as part of resuscitation and stabilization prior to endoscopy or surgery.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | Use when reporting a service with a distinct professional interpretation component tied to a separately payable service (rare for drug administration; typically not appended to unless paired with a separately reportable professional interpretation). |